Baseline characteristics of the initial cohort
| Group . | . | . | . | . | . |
|---|---|---|---|---|---|
| Health controls | ID | Sex | Age | ||
| PB | PB1 | M | 28 | ||
| PB2 | F | 25 | |||
| PB3 | F | 41 | |||
| PB4 | F | 71 | |||
| PB5 | F | 62 | |||
| PB6 | M | 33 | |||
| PB7 | F | 26 | |||
| PB8 | F | 27 | |||
| PB9 | M | 26 | |||
| PB10 | F | 58 | |||
| PB11 | F | 56 | |||
| PB12 | F | 28 | |||
| PB13 | F | 31 | |||
| PB14 | F | 26 | |||
| BM | BM1 | F | 75 | ||
| BM2 | F | 28 | |||
| BM3 | M | 38 | |||
| BM4 | M | 54 | |||
| Acute leukemias | ID | Sex | Age | Blasts (BM) | |
| ALL | ALL1 | M | 20 | 96 | |
| ALL2 | M | 12 | 46 | ||
| ALL3 | M | 1 | 93 | ||
| ALL4 | F | 3 | 92 | ||
| ALL5 | F | 19 | 99 | ||
| AML | AML1 | M | 26 | 90 | |
| AML2 | F | 90 | 90 | ||
| AML3 | F | 64 | 80 | ||
| AML4 | F | 84 | 31 | ||
| AML5 | F | 56 | 90 | ||
| AML6 | M | 23 | 30 | ||
| AML7 | F | 58 | 80 | ||
| AML8 | F | 1 | 72 | ||
| AML9 | M | 74 | 87 | ||
| AML10 | F | 72 | 90 | ||
| AML11 | F | 55 | 95 | ||
| AML12 | F | 36 | 93 | ||
| AML13 | M | 75 | 33 | ||
| AML14 | F | 51 | 75 | ||
| AML15 | F | 45 | 77 | ||
| AML16 | M | 65 | 46 | ||
| AML17 | M | 52 | 90 | ||
| TBD | ID | Sex | Age | Telomere length (percentile) | Germ line variant |
| TBD | TBD1 | F | 20 | <1 | TINF2/p.R282C |
| TBD2 | M | 10 | <10 | DKC1/p.A353V | |
| TBD3 | F | 16 | <10 | TERT/p.R865H | |
| TBD4 | M | 40 | <1 | Not identified | |
| TBD5 | F | 35 | <1 | Not identified | |
| TBD6 | F | 64 | <1 | Not identified | |
| TBD7 | M | 57 | <10 | TERC/r.C94T | |
| TBD8 | M | 59 | 30 | TERT/p.R865H | |
| TBD9 | M | 27 | <1 | TERT/p.R865H | |
| Group . | . | . | . | . | . |
|---|---|---|---|---|---|
| Health controls | ID | Sex | Age | ||
| PB | PB1 | M | 28 | ||
| PB2 | F | 25 | |||
| PB3 | F | 41 | |||
| PB4 | F | 71 | |||
| PB5 | F | 62 | |||
| PB6 | M | 33 | |||
| PB7 | F | 26 | |||
| PB8 | F | 27 | |||
| PB9 | M | 26 | |||
| PB10 | F | 58 | |||
| PB11 | F | 56 | |||
| PB12 | F | 28 | |||
| PB13 | F | 31 | |||
| PB14 | F | 26 | |||
| BM | BM1 | F | 75 | ||
| BM2 | F | 28 | |||
| BM3 | M | 38 | |||
| BM4 | M | 54 | |||
| Acute leukemias | ID | Sex | Age | Blasts (BM) | |
| ALL | ALL1 | M | 20 | 96 | |
| ALL2 | M | 12 | 46 | ||
| ALL3 | M | 1 | 93 | ||
| ALL4 | F | 3 | 92 | ||
| ALL5 | F | 19 | 99 | ||
| AML | AML1 | M | 26 | 90 | |
| AML2 | F | 90 | 90 | ||
| AML3 | F | 64 | 80 | ||
| AML4 | F | 84 | 31 | ||
| AML5 | F | 56 | 90 | ||
| AML6 | M | 23 | 30 | ||
| AML7 | F | 58 | 80 | ||
| AML8 | F | 1 | 72 | ||
| AML9 | M | 74 | 87 | ||
| AML10 | F | 72 | 90 | ||
| AML11 | F | 55 | 95 | ||
| AML12 | F | 36 | 93 | ||
| AML13 | M | 75 | 33 | ||
| AML14 | F | 51 | 75 | ||
| AML15 | F | 45 | 77 | ||
| AML16 | M | 65 | 46 | ||
| AML17 | M | 52 | 90 | ||
| TBD | ID | Sex | Age | Telomere length (percentile) | Germ line variant |
| TBD | TBD1 | F | 20 | <1 | TINF2/p.R282C |
| TBD2 | M | 10 | <10 | DKC1/p.A353V | |
| TBD3 | F | 16 | <10 | TERT/p.R865H | |
| TBD4 | M | 40 | <1 | Not identified | |
| TBD5 | F | 35 | <1 | Not identified | |
| TBD6 | F | 64 | <1 | Not identified | |
| TBD7 | M | 57 | <10 | TERC/r.C94T | |
| TBD8 | M | 59 | 30 | TERT/p.R865H | |
| TBD9 | M | 27 | <1 | TERT/p.R865H | |
F, female; M, male.